-
公开(公告)号:EP4004053A1
公开(公告)日:2022-06-01
申请号:EP20848658.9
申请日:2020-07-27
申请人: ABL Bio, Inc. , Yuhan Corporation
-
公开(公告)号:EP4403218A2
公开(公告)日:2024-07-24
申请号:EP24170761.1
申请日:2018-12-14
申请人: ABL Bio, Inc.
发明人: AHN, Jinhyung , AN, Sungwon , KIM, Dongin , SUNG, Eunsil , EOM, Jaehyun , LEE, Sang Hoon , YOU, Weonkyoo , KIM, Juhee , PARK, Kyungjin , CHUNG, Hyejin , JUNG, Jinwon , LEE, Bora , SUNG, Byungje , KIM, Yeunju , SON, Yong-Gyu , AHN, Seawon , SONG, Daehae , YOO, Jiseon , PAK, Youngdon , YEOM, Donghoon , LEE, Yoseob , JUNG, Jaeho
IPC分类号: A61P25/00
CPC分类号: C07K16/2863 , C07K16/18 , C07K2317/3120130101 , C07K2317/9420130101 , C07K2317/9220130101 , C07K2317/7720130101 , A61P25/16 , C07K2317/2120130101 , C07K2317/2420130101 , C07K2317/3420130101 , C07K2317/3520130101 , C07K2317/52620130101 , C07K2317/56520130101 , C07K2317/62220130101 , C07K2317/3320130101 , A61K2039/50520130101 , A61P25/00
摘要: The present invention relates to a bi-specific antibody that specifically binds to alpha-synuclein and IGF1R, and use of the bi-specific antibody for treating or diagnosing synucleinopathies associated with alpha-synuclein or alpha-synuclein aggregates. The IGF1R portion of the bi-specific antibody acts as a shuttle to penetrate the blood brain barrier, allowing the alpha-synuclein portion to exert its action in the brain. Further, the half-life of the bi-specific antibody may be extended to maintain efficacy over time.
-
公开(公告)号:EP3777895A1
公开(公告)日:2021-02-17
申请号:EP19826406.1
申请日:2019-06-26
申请人: ABL Bio Inc.
发明人: PARK, Kyungjin , CHUNG, Hyejin , PARK, Kyeongsu , LEE, Yangsoon , CHANG, Mikyung , JEON, Jaehyoung , KIM, Youngkwang , JEONG, Junhyun , YOO, Jiseon , KIM, Yeunju , YEOM, Donghoon , KIM, Eunjung , LEE, Bora , JUNG, Jinwon
摘要: Provided are an antibody or antigen-binding fragment thereof that specifically binds to a B-cell maturation antigen (BCMA), a method of preparing the same, and use thereof. Accordingly, these can be utilized in effectively preventing or treating cancers.
-
公开(公告)号:EP4403218A3
公开(公告)日:2024-11-06
申请号:EP24170761.1
申请日:2018-12-14
申请人: ABL Bio, Inc.
发明人: AHN, Jinhyung , AN, Sungwon , KIM, Dongin , SUNG, Eunsil , EOM, Jaehyun , LEE, Sang Hoon , YOU, Weonkyoo , KIM, Juhee , PARK, Kyungjin , CHUNG, Hyejin , JUNG, Jinwon , LEE, Bora , SUNG, Byungje , KIM, Yeunju , SON, Yong-Gyu , AHN, Seawon , SONG, Daehae , YOO, Jiseon , PAK, Youngdon , YEOM, Donghoon , LEE, Yoseob , JUNG, Jaeho
摘要: The present invention relates to a bi-specific antibody that specifically binds to alpha-synuclein and IGF1R, and use of the bi-specific antibody for treating or diagnosing synucleinopathies associated with alpha-synuclein or alpha-synuclein aggregates. The IGF1R portion of the bi-specific antibody acts as a shuttle to penetrate the blood brain barrier, allowing the alpha-synuclein portion to exert its action in the brain. Further, the half-life of the bi-specific antibody may be extended to maintain efficacy over time.
-
公开(公告)号:EP3797124A1
公开(公告)日:2021-03-31
申请号:EP19806701.9
申请日:2019-05-23
申请人: ABL Bio Inc.
发明人: LEE, Yangsoon , KIM, Juhee , PARK, Kyungjin , YEOM, Donghoon , PARK, Kyeongsu , CHUNG, Hyejin , KIM, Yeunju , PARK, Eunyoung , JUNG, Uijung , SUNG, Eunsil , AHN, Jinhyung , SUNG, Byungje , SONG, Daehae , PAK, Youngdon
IPC分类号: C07K16/28 , C07K16/40 , A61K47/68 , A61P35/00 , G01N33/574
-
公开(公告)号:EP4387997A1
公开(公告)日:2024-06-26
申请号:EP21858577.6
申请日:2021-08-18
申请人: ABL Bio, Inc.
发明人: PARK, Kyungjin , LEE, Yangsoon , LIM, Saeyi , PARK, Kyeongsu , SEON, Minkyu , SON, Wonjun , CHUNG, Hyejin , YONG, Yeryoung , SON, Yong-Gyu , KIM, Yeunju , PAK, Youngdon
-
公开(公告)号:EP3887403A1
公开(公告)日:2021-10-06
申请号:EP19890588.7
申请日:2019-12-02
申请人: ABL Bio Inc.
发明人: PARK, Eunyoung , LEE, Yangsoon , CHUNG, Hyejin , JUNG, Uijung , PAK, Youngdon , JEONG, Jun Hyun , KIM, Yeunju , AHN, Seawon , SUNG, Byungje
-
公开(公告)号:EP3802612A1
公开(公告)日:2021-04-14
申请号:EP19807093.0
申请日:2019-05-24
申请人: ABL Bio Inc.
发明人: PARK, Kyeongsu , LEE, Yangsoon , CHUNG, Hyejin , JUNG, Uijung , SON, Yong-Gyu , HA, Sang-Jun , KIM, Myeong Joon , PARK, Eunyoung , PARK, Kyungjin , SUNG, Eunsil , KIM, Yeunju , AHN, Jinhyung , SUNG, Byungje , SONG, Daehae , PAK, Youngdon
IPC分类号: C07K16/28 , A61K47/68 , A61P35/00 , G01N33/574 , A61K39/00
-
公开(公告)号:EP3725806A1
公开(公告)日:2020-10-21
申请号:EP18889608.8
申请日:2018-12-14
申请人: ABL Bio Inc.
发明人: AHN, Jinhyung , AN, Sungwon , KIM, Dongin , SUNG, Eunsil , EOM, Jaehyun , LEE, Sang Hoon , YOU, Weonkyoo , KIM, Juhee , PARK, Kyungjin , CHUNG, Hyejin , JUNG, Jinwon , LEE, Bora , SUNG, Byungje , KIM, Yeunju , SON, Yong-gyu , AHN, Seawon , SONG, Daehae , YOO, Jiseon , PAK, Youngdon , YEOM, Donghoon , LEE, Yoseob , JUNG, Jaeho
摘要: The present invention relates to a bi-specific antibody that specifically binds to alpha-synuclein and IGF1R, and an use of the bi-specific antibody for the prevention, treatment and / or diagnosis of synucleinopatheis associated with alpha-synuclein or alpha-synuclein aggregates, and can allow the alpha-synuclein antibody or an antigen-binding fragment thereof to penetrate the blood brain barrier to exert its action in the brain, and extend the half-life to maintain the efficacy for a long time.
-
公开(公告)号:EP3725802A2
公开(公告)日:2020-10-21
申请号:EP18879299.8
申请日:2018-11-16
申请人: ABL Bio Inc.
发明人: LEE, Sang Hoon , YOU, Weonkyoo , AHN, Jinhyung , AN, Sungwon , JUNG, Jinwon , LEE, Bora , KIM, Dongin , SUNG, Byungje , SON, Yonggyu , KIM, Yeunju , EOM, Jaehyun , AHN, Seawon , PAK, Youngdon , YEOM, Donghoon , SONG, Daehae
摘要: The present invention relates to an anti-alpha-synuclein antibody preferentially recognizing alpha-synuclein aggregates and a use of detection, diagnosis, and/or treatment or prevention of various diseases caused by accumulation of alpha-synuclein aggregates, or their related symptom diseases by using the anti-alpha-synuclein antibody.
-
-
-
-
-
-
-
-
-